中國核建(601611.SH):華辰建工擬吸收合併中核華辰
格隆匯 11 月 27日丨中國核建(601611.SH)公佈,公司召開第三屆董事會第二十次會議,通過了《關於審議華辰建工吸收合併中核華辰的議案》。
公司子公司中核華辰建設有限公司(“中核華辰”)主要依託其全資子公司中核華辰建築工程有限公司(“華辰建工”)開展主營業務,吸收合併後中核華辰註銷,華辰建工存續並承繼中核華辰全部資產、負債、權益、人員和業務,不影響華辰建工的持續經營能力,同時能夠實現壓減法人層級的目的。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.